01 2ABBVIE
01 28471025
01 2Y
01 2Blank
01 22031-08-12
Patent Expiration Date : 2031-08-12
US Patent Number : 8471025
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 217906
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-12
Patent Expiration Date : 2031-08-12
US Patent Number : 8471025
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 206494
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-08-12
